Graupp M, Hackl G 13.01.2014 1 - Med Uni...
Transcript of Graupp M, Hackl G 13.01.2014 1 - Med Uni...
-
Graupp M, Hackl G
113.01.2014
-
Scand J Rheumatol
13.01.2014 2
-
13.01.2014 3
Jenette JC et al. Arthritis Rheum. 2013 Jan;65(1):1‐11.
Wegener´s granulomatosis
-
• First discribed in 1936• Granulomatous inflammation ofupper (ENT) and lower airways(lungs) > 90% and kidneys in 85%
• Necrotizing vasculitis of small andmedium‐sized vessels
• Aetiology still unknown• 2013: Granulomatosis withPolyangiitis
13.01.2014 4
Friedrich Wegener, deutscher Pathologe; *4.April 1907 in Varel; †9.Juli 1990 in Lübeck
Wegener´s granulomatosis
-
Diagnostic criteria
13.01.2014 5
Wegener´s granulomatosis
2012 Revised International Chapel HillConsensus Conference Nomenclatureof Vasculitides ‐ CHCC
Necrotizing granulomatous inflammationusually involving the upper and lowerrespiratory tract, and necrotizing vasculitisaffecting predominantly small to mediumvessels (e.g., capillaries, venules, arterioles, arteries and veins). Necrotizingglomerulonephritis is common.
-
• Mean age at diagnosis is around60 years
• Life expectancy around 5 monthsin the 1950s
• Nowadays decades after diagnosis– Cytotoxic drugs
• (Corticosteroids)• Cyclophosphamide
• Untreated, renal failure is fatal• Today long time on dialysis
possible– After receiving kidney transplant
fairly normal life
13.01.2014 6
Wegener´s granulomatosis
Geetha D et al. Am J Transplant 2007
-
• To analyse the prognostic factors and causesof death in patients diagnosed withWegener´s granulomatosis over a 20 yearperiod, from 1981 to 2000 in Finland.
13.01.2014 7
Aim of the study
• Retrospective prognostic study
-
• Hospital discharge register (National Research andDevelopment Centre for Welfare and Health, STAKES,Finland) screened
• Patients with discharge diagnosis of WG– In specialized medical care– In 1981 – 2000
• 1981 – 1986 based on ICD‐8• 1987 – 1995 based on ICD‐9• 1996 – 2000 based on ICD‐10
• One (!) author ascertained diagnosis– on the grounds of cumulative clinical features– laboratory findings– ACR criteria
13.01.2014 8
Patients and methods
-
• What were the key selection criteria?• Diagnosis of WG (ACR)
• Were inclusion criteria appropriate given?• Yes
• Were participants at a common point in thecourse of their disease?
• Yes („de novo“ diagnosis)
13.01.2014 9
Patients and methods
-
• Study period from 1 January 1981 to 31December 2000 devided into two subperiods– 1981 – 1990– 1991 – 2000
• End of follow‐up: 30 July 2005• From Statistics Finland information who died bythe end of follow‐up– When WG cause of death, immediate cause of deathwas recorded (if available)
13.01.2014 10
Patients and methods
-
• What outcome measures were used?• Date of Death; Cause of Death
• Was follow up time sufficiently long to detectimportant prognostic facors?
• Yes; study period 1981‐2000; end of follow up 2005
13.01.2014 11
Patients and methods
-
• Results expressed as– Means (± SD)– Medians (+ IQRs)– 95% confidence intervals
• Groups compared– Mann‐Whitney U‐test– χ2‐test
• Cox Regression used to estimate risk formortality (age and sex adjusted)
• Kaplan Meier curves to visualize survival
13.01.2014 12
Statistics
-
• Standardized mortalitiy ratio (SMR)– Ratio between oberseved and expected numbers
• Probabilities of survival (age and sex adjustedsample of general population) calculated fromthe Official Statistics of Finland data
• Ethical aspects adhered
– SMR => Poission distribution ?
13.01.2014 13
Statistics
-
Patient´s characteristics• n = 492 (243 men, 249 women)• 83% fulfilled ACR criteria
• ACR neg group older (mean age 57.18 vs. 52.36 years; p
-
Treatment characteristics• 75.4% (1981 – 1990) and 78.1% (1991 – 2000) treatedwith cyclophosphamide– in females frequently started later (55% vs. 35% 6 or moremonths after first symptoms)
• median cumulative dose smaller for women (32.6 g) than for men(41.6 g)
– 4.3% never received cyclophosphamide
• 87.3% (1981 – 1990) and 93.7% (1991 – 2000) treatedwith glucocorticoids
• 5 treated with TNF‐α blocker• long‐term antibiotic medication use increased tosecond decade (16.7% vs. 28.2%)
13.01.2014 15
Results
-
Survival of WG patients• Of the 492 patients, 203 (99 men and 104women) died before the end of June 2005
13.01.2014 16
Results
-
Survival of WG patients
13.01.2014 17
Results
n.s.
n.s.
-
Predictors of survival
• Older age and elevated creatinine levelshorter survival time
• ENT symptoms and cyclophosphamidebetter outcome
• long‐term antibiotic better prognosis(p< 0.005)
• ANCA‐neg better prognosis than ANCA‐pos (but difference n.s.)
– patients not tested for ANCA had the worstmortality, particularly diagnosed in 19811990 (p< 0.05)
13.01.2014 18
Results
-
• Dialysis as predictor– n = 48; increased mortality rate early in disease
13.01.2014 19
Results
-
Standardized mortalitiy ratio (SMR) 1981‐2000• All: 3.43 (95% CI 2.98‐3.94)• Women: 4.38 (95% CI 3.59‐5.61)• Men: 2.80 (95% CI 2.28‐3.41)
13.01.2014 20
Results
-
• What measures of prognosis & differences betweengroups were reported?
• (1‐) 5 year‐survival rate; HR; SMR
• Could useful estimates of prognosis be calculated?• Yes
• What was the magnitude and direction of prognosticestimates?
• Older age, renal impairment => poor outcome• ENT and cyclophosphamide => favor prognosis• SMR 3.43
13.01.2014 21
Results
-
• Was the source population for participantswell described? Representative?
• Were the characteristics of the study settingwell described? Retrospective study
• Would the prognostic information have animportant impact on patient or practitionerdecisions?
13.01.2014 22
Study applicability
-
Thanks for your attention!
13.01.2014 23